Literature DB >> 4801623

Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report.

T Okuma, A Kishimoto, K Inoue, H Matsumoto, A Ogura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4801623     DOI: 10.1111/j.1440-1819.1973.tb02661.x

Source DB:  PubMed          Journal:  Folia Psychiatr Neurol Jpn        ISSN: 0015-5721


× No keyword cloud information.
  24 in total

1.  Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study.

Authors:  T Okuma; K Inanaga; S Otsuki; K Sarai; R Takahashi; H Hazama; A Mori; M Watanabe
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

2.  Extended-release carbamazepine capsules: a viewpoint.

Authors:  Richard H Weisler
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Extended-release carbamazepine capsules: a viewpoint.

Authors:  Philip B Mitchell
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Drug alternatives to lithium in manic-depressive disorders.

Authors:  D M Shaw
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 5.  Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

Authors:  Robert M Post; Terence A Ketter; Thomas Uhde; James C Ballenger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

Review 7.  Review of clinically important drug interactions with lithium.

Authors:  N S Harvey; S Merriman
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

8.  Effects of carbamazepine and anti-depressant drugs on endogenous catecholamine levels in the cerebroventricular compartment of the rat.

Authors:  S Kowalik; M Levitt; A I Barkai
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 9.  The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Authors:  C Simhandl; K Meszaros
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

10.  Carbamazepine extended-release capsules in bipolar disorder.

Authors:  Richard H Weisler
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.